Tag: congress
SSDP Joins Letter to Protect 7-OH (Kratom related Substance)
A broad coalition of consumer advocates and drug-policy reform groups recently sent a letter to the House Judiciary Committee Chairman, Jim Jordan, encouraging Congress not to ban 7-hydroxymitragynine (7-OH), a compound related to kratom. The entire letter is included at the bottom of this blog post. The letter argues that the FDA’s push to schedule 7-OH under the Controlled Substances
Announcing the SSDP Congressional Session 2024 Results
Students for Sensible Drug Policy is proud to announce our elected 2024 board directors!
Announcing the SSDP Congressional Session 2023 Results
CONGRATULATIONS TO THE 2023 ELECTED BOARD MEMBERS! SSDP’s Congress Committee is excited to announce we have finalized the results of the Board of Directors election! Please join me in extending a warm welcome to our new Board members, Justin Ayala, Amanda Ivatorov, and Hena Malik! SSDP’s 2023 Elected Board Directors A ROUND OF APPLAUSE FOR OUR 2023 BOARD OF DIRECTORS
